| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/29/2009 | US7638324 Useful in modulating apoptosis; diagnosis of prostate/ovarian cancer, and leukemia |
| 12/29/2009 | US7638323 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 12/29/2009 | US7638322 vascular endothelial growth factor (VEGF); ischemic heart disease |
| 12/29/2009 | US7638312 E.coli mutant containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same |
| 12/29/2009 | US7638305 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 12/29/2009 | US7638304 Hybrid fusion protein transcription regulator to induce interferon target gene expression |
| 12/29/2009 | US7638303 Soluble ErbB3 receptor isoforms |
| 12/29/2009 | US7638302 Soluble ErbB3 receptor isoforms |
| 12/29/2009 | US7638301 Prodomain modulators of ADAM 10 |
| 12/29/2009 | US7638300 In vivo incorporation of unnatural amino acids |
| 12/29/2009 | US7638299 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 12/29/2009 | US7638296 culturing in a medium containing insulin; use in the treatment of anemia; industrial scale production; high quality, purity |
| 12/29/2009 | US7638289 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 12/29/2009 | US7638286 producing an antibody by inoculating an animal with a polypeptide; monoclonal antibody specifically binds to a zalpha11 polypeptide; treating blood disorders |
| 12/29/2009 | US7638284 analysis; detect IgA deficiency in a mammal, using antibody specific for Immunoglobulin A Inducing Protein; polyclonal antibody; monoclonal antibody; immunoassay for mammalian mucosal immune system |
| 12/29/2009 | US7638283 Amyloid β protein (globular assembly and uses thereof) |
| 12/29/2009 | US7638282 Genes of an otitis media isolate of nontypeable Haemophilus influenzae |
| 12/29/2009 | US7638281 Polypeptide, cDNA encoding the same and use of them |
| 12/29/2009 | US7638279 Preferential nucleotide sequences for use in in the detection, quantitation and/or analysis of nucleic acids |
| 12/29/2009 | US7638277 Diagnosing ovarian cancer by detecting a TADG-12 protein in biological sample, immunoaffinity to an antibody, bioassay, immunoassay |
| 12/29/2009 | US7638270 Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer |
| 12/29/2009 | US7638269 Viral capsid assembly intermediates and methods of production |
| 12/29/2009 | US7638149 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 12/29/2009 | US7638136 fusion proteins; encode hyperimmune serum reactive antigen or fragment thereof; immunogens |
| 12/29/2009 | US7638133 transformed with an expression vector that has a polynucleotide encoding a foreign antigenic protein, wherein the polynucleotide is a modified one in which the third position of each codon is substituted with G or C without a change of an amino acid; against human immunodeficiency virus infection |
| 12/29/2009 | US7638131 Coccidiosis poultry vaccine |
| 12/29/2009 | US7638130 Modified obligate parasite polypeptide for use in treatment and prevention of scrub typhus infection |
| 12/29/2009 | US7638129 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 12/29/2009 | US7638128 Reducing apoptosis and/or tissue injury due to cardiac ischemia via exposure of tissue to mixture comprising secreted frizzled related protein (Sfrp) and a paracrine factor of a mesenchymal stem cells (MSC); tissue engineering and repair |
| 12/29/2009 | US7638126 Methods of treating pain and inflammation in neuronal tissue using antagonists of IL-31, IL31Ra and/or OSMRb |
| 12/29/2009 | CA2331783C Chemically modified proteins with a carbohydrate moiety |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/29/2009 | CA2153507C A fas ligand, a fragment thereof and dna encoding the same |
| 12/29/2009 | CA2147839C The st-b17 serotonin receptor |
| 12/25/2009 | WO2009076737A1 Production of recombinant bos taurus growth hormone with pichia pastoris |
| 12/25/2009 | CA2746905A1 Production of recombinant bos taurus growth hormone with pichia pastoris |
| 12/24/2009 | US20090320159 Nucleic acid compositions conferring disease resistance |
| 12/24/2009 | US20090320158 Protein Kinase Stress-Related Proteins and Methods of Use in Plants |
| 12/24/2009 | US20090320157 Transgenic freeze and drought resistant plants; crops with enhanced resistance to enviromental stresses; plant transformed by a Protein Kinase Stress-Related Protein (PKSRP) coding nucleic acid |
| 12/24/2009 | US20090318677 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 12/24/2009 | US20090318673 Method of changing fluorescence wavelength of fluorescent protein |
| 12/24/2009 | US20090318672 Antibodies to pro352 |
| 12/24/2009 | US20090318671 Novel canola protein isolate |
| 12/24/2009 | US20090318666 Synthetic Dog/Human Chimeric C-C Chemokine Receptor 2B |
| 12/24/2009 | US20090318365 Metastin derivatives and use thereof |
| 12/24/2009 | US20090318360 Use of the neurotoxic component of a botulinum toxin for treating arthritis |
| 12/24/2009 | US20090318359 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
| 12/24/2009 | US20090318358 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains |
| 12/24/2009 | US20090318354 Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1) |
| 12/24/2009 | US20090318353 Acylated Exendin-4 Compounds |
| 12/24/2009 | US20090318352 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
| 12/24/2009 | US20090318350 Pan-her antagonists and methods of use |
| 12/24/2009 | US20090318349 Transglutaminase variants with improved specificity |
| 12/24/2009 | US20090318348 Proteins, Nucleic Acids Encoding the Same, and Associated Methods of Use |
| 12/24/2009 | US20090318347 Novel compounds and their effects on feeding behaviour |
| 12/24/2009 | US20090318346 BIVALENT ErbB LIGAND BINDING MOLECULES AND METHODS FOR THEIR PREPARATION AND USE |
| 12/24/2009 | US20090318344 Compositions and methods for modulating hemostasis using variant forms of activated factor v |
| 12/24/2009 | US20090318342 Compounds |
| 12/24/2009 | US20090318340 IL-17 homologous polypeptides and therapeutic uses thereof |
| 12/24/2009 | US20090318333 Modified Metallothioneins and Methods for Screening and Treatment of Diseases Associated With Oxidative Stress |
| 12/24/2009 | US20090318299 Development and use of fluorescent probes of unbound analytes |
| 12/24/2009 | US20090317905 nucleotide sequences coding potassium chanel protein for use in identifying modulator for prevention and treatment of cardiovascular/myocardial disorders; utilized to diagnose and screen for short QT syndrome, long QT syndrome, Brugada syndrome and progressive conduction disease |
| 12/24/2009 | US20090317891 Plant activation of insect toxin |
| 12/24/2009 | US20090317868 Rapidly Cleavable Sumo Fusion Protein Expression System for Difficult to Express Proteins |
| 12/24/2009 | US20090317855 Receptor-mediated delivery: compositions and methods |
| 12/24/2009 | US20090317827 Receptor In Dendritic Cells |
| 12/24/2009 | US20090317816 Methods for identifying risk of breast cancer and treatments thereof |
| 12/24/2009 | US20090317808 Novel nucleotide and amino acid sequences and methods of use thereof for diagnosis |
| 12/24/2009 | US20090317457 Anti-inflammatory and wound healing effects of lymphoid thymosin b-4 |
| 12/24/2009 | US20090317428 Immunogenic T-Helper Epitopes From Human Tumour Antigens and Immunotherapeutic Methods Using Said Epitopes |
| 12/24/2009 | US20090317420 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| 12/24/2009 | US20090317413 Detection of human platelet antigen (hpa) antibodies |
| 12/24/2009 | US20090317410 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 12/24/2009 | US20090317398 a labeled polyclonal antibody, monoclonal antibody or antigen-binding fragment which preferentially binds to a polypeptide that chemoattracts peripheral blood monocytes or T-cells; proteins which control development, differentiation, trafficking and physiology of mammalian cells; immunology |
| 12/24/2009 | US20090317397 Soluble CTLA4 mutant molecules and uses thereof |
| 12/24/2009 | US20090317395 Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP) |
| 12/24/2009 | US20090317393 Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
| 12/24/2009 | US20090317391 Cancer Related Genes (PTPE) |
| 12/24/2009 | US20090317379 Autophilic antibodies and method of making the same |
| 12/24/2009 | US20090317368 B7-h1, a novel immunoregulatory molecule |
| 12/24/2009 | US20090317363 Cytokine Derivatives |
| 12/24/2009 | US20090317358 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities |
| 12/24/2009 | US20090317333 Protein kinase a reporters useful in high throughput assays |
| 12/24/2009 | US20090317332 Human g protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto |
| 12/24/2009 | US20090314660 Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin |
| 12/24/2009 | DE19624332B4 Metallische Nanostruktur auf der Basis hochgeordneter Proteine sowie Verfahren zu deren Herstellung Metallic nanostructures on the basis of highly ordered proteins and methods for their manufacture |
| 12/24/2009 | DE102008029045A1 Protein(s), useful for combating arthropods, preferably insects, where the protein(s) is/are related to naturally occurring proteins in bacteria and has structural characteristic based on the toxic effect of the protein(s) on arthropods |
| 12/23/2009 | WO2009155504A2 Methods for the modulation of angiogenesis |
| 12/23/2009 | WO2009155484A2 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
| 12/23/2009 | WO2009155476A2 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains |
| 12/23/2009 | WO2009155373A1 Nucleotide and protein sequence of guinea pig il-6 and methods of use |
| 12/23/2009 | WO2009155324A2 Pigf-1 assay and kits and components thereof |
| 12/23/2009 | WO2009155258A2 Glucagon/glp-1 receptor co-agonists |
| 12/23/2009 | WO2009155064A1 Bifunctional molecules for inhibiting hiv entry |
| 12/23/2009 | WO2009155055A2 Methods of effecting wnt signaling through dkk structural analysis |
| 12/23/2009 | WO2009154573A1 Modulators of stat3 signalling |
| 12/23/2009 | WO2009154565A1 Combination therapies against cancer |
| 12/23/2009 | WO2009154452A1 Parvoviral capsid with incorporated Gly-Ala repeat region |
| 12/23/2009 | WO2009154334A1 Iborange gene involved in carotenoid accumulation from ipomoea batatas |
| 12/23/2009 | WO2009154264A1 Peptide |